For the full report please write to info@netscribes.com

1. Bio Pharma Market – India
June 2017
Insert Cover Image using Slide Master View
Do not change the aspect ratio or distort the image.

2. Bio Pharma Market in India 2017
Executive Summary
Market Overview
Drivers and
Challenges
Competitive
Landscape
 While historically the biopharmaceuticals market in India has grown at a CAGR of x%, it is expected to grow at a CAGR of x% between 2016 and 2022,
to reach a value of INR x bn at the end of the period
 Indian bio pharma companies are currently working on over 100 bio pharma products which are at various stages of development
 Indian vaccine manufacturers cater to x% of the total vaccine demand for childhood vaccination in over 100 countries
Drivers
 Changing demographics
 Increasing per capita disposable income and healthcare
spending
 Growing pharmaceutical industry
 Government initiatives to develop the sector
 Strong vaccine development capabilities
Challenges
 Lack of regulatory clarity
 Operational and technological challenges
 Intense competition from other Asian countries
2
Major Players
Biocon Ltd. Cadila Healthcare Ltd. Dr. Reddy’s Laboratories Ltd. GlaxoSmithKline Pharmaceuticals Ltd.
Lupin Ltd. Wockhardt Ltd. Haffkine Bio-Pharmaceutical Corporation Ltd. Serum Institute of India Pvt. Ltd.
Market Overview
 India emerging as the next biotechnology hub
 Rising Biopharmaceutical outsourcing to India
 Biosimilars market gaining strong foothold in India

3. Socioeconomic Indicators
Market Overview
Market Influencers
Competitive Landscape
Recent Developments
Appendix
3
Trade Analysis
Market Trends

4. Bio Pharma Market in India 2017
Socioeconomic Indicators
Total Population
4
Population Density
1,000
500
1,500
0
mn
2019 2020
X%
2010 201820172012 2013 2015 20162011 2014
0
100
200
300
400
500
2015 2016 2017 2018 2019 2020
X%
2010 2011 2013 20142012
Persons per sq. km

5. Bio Pharma Market in India 2017
Market Definition & Structure
5
• Biotechnology refers to technology based on biology
• It harnesses cellular and biomolecular processes to develop technologies and products that help improve lives and health
• Biopharmaceuticals are medical drugs produced using biotechnology
• They are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes, and are produced by means other
than direct extraction from a native (non-engineered) biological source
Biotechnology (Healthcare)
xx xx xx xx
xxxx
Focus of the study
Bioservices Biopharmaceuticals
xx
xx xx
xx

6. Bio Pharma Market in India 2017
Market Overview
6
Biopharmaceuticals Market Size & Growth Forecast – Value-Wise (Historical)
Biopharmaceuticals Market Size & Growth Forecast – Value-Wise (Forecasted)
0
50
100
150
200
250
INR bn
+x%
2016201520142013201220112010
0
100
200
300
400
500
2022e2021e2020e2019e2018e2017e2016
+x%
INR bn

7. Bio Pharma Market in India 2017
Market Overview
7
Current Market Scenario
• Biotechnology activities started in India more than three decades ago when various vaccines and enzymes production facilities were set up on a small scale
• Subsequently, biotechnology companies scaled up with innovative techniques and research to launch a wide variety of products in the field of medicine, agriculture, healthcare and
industrial goods
• At present, biopharmaceuticals account for the largest share in India’s biotechnology industry
• While historically the biopharmaceuticals market in the country grew at a CAGR of x%, it is expected to grow at a CAGR of x% between 2016 and 2022, to reach a value of INR xbn at
the end of the period
• xx

8. Bio Pharma Market in India 2017
Porter’s Five Forces Analysis
8
• xx
• xx
• xx
• xx
Competitive Rivalry
• xx
Bargaining Power
of Suppliers
Threat of New
Entrants
Bargaining Power
of Buyers
Threat of
Substitutes
SAMPLE

9. Bio Pharma Market in India 2017
SAMPLE
9
Export (Value)
0
10,000
20,000
30,000
40,000
50,000
+x%
FY 2017FY 2016FY 2015FY 2014FY 2013
INR mn
0
1,000
2,000
3,000
4,000
5,000
‘000 Kgs
+x%
FY 2017FY 2016FY 2015FY 2014FY 2013
Export (Volume)
Export – HS Code 300220
HS Code 300220 refers to vaccines for human medicine

10. Bio Pharma Market in India 2017
SAMPLE
Export Segmentation – HS Code 300220
10
Country-Wise Segmentation (Value-Wise)
FY 2016 FY 2017
Country-Wise Segmentation (Volume-Wise)
Others
Brazil
Egypt
Ethiopia
Congo
Kenya
Nigeria
FY 2016 FY 2017
HS Code 300220 refers to vaccines for human medicine
Others
Bangladesh
Iran
Pakistan
Philippines
Brazil
Nigeria
Philippines
Congo
Ethiopia
Nigeria
Others
Mexico
Kenya
Ethiopia
Others
Mexico
Pakistan
Philippines
Nigeria
Brazil

11. Bio Pharma Market in India 2017
Market Drivers
11
• Per capita disposable income in India is
increasing at a steady rate
• xx
Increasing per capita disposable income and
healthcare spending
• The Indian pharmaceuticals market is the
xth largest in terms of volume and yth
largest in terms of value globally
 xx
Growing pharmaceutical industry
• Changing demographic structure of India
has led to an increased demand for various
healthcare services and pharmaceutical
products, including biopharmaceuticals
• xx
Changing demographics

12. Bio Pharma Market in India 2017
Key Trends
12
Major Trends Observed in the Indian Bio Pharma Market
• India's biotechnology sector has attracted major investments from several global companies due to its strong generic biotechnology potential
• xx
India emerging as
the next
biotechnology hub
• India is being recognized globally as a preferred outsourcing destination for contract research and manufacturing services (CRAMS)
• xxRising
Biopharmaceutical
outsourcing to
India
• Most major pharmaceutical firms operating in the country are conducting R&D activities to develop generic equivalents of biologic drugs known as
biosimilars
• xx
Biosimilars market
gaining strong
foothold in India

13. Bio Pharma Market in India 2017
Competition
13
List of Major Players
Name Website
Biocon Ltd.
Cadila Healthcare Ltd.
Dr. Reddy’s Laboratories Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
Lupin Ltd.
Wockhardt Ltd.
Haffkine Bio-Pharmaceutical Corporation Ltd.
Intas Pharmaceuticals Ltd.
Reliance Life Sciences Pvt. Ltd.
Serum Institute of India Pvt. Ltd.

14. Bio Pharma Market in India 2017 14
Company Information
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation
Business Description
• xx
Public: Domestic Company – Company A
Products and Services
Category Products/Services
xx xx
xx xx
xx xx
xx xx
Key People
Name Designation
Person 1 Chief Executive Officer
Person 2 Chief Operating Officer
Person 3 Head – Operations
Person 4 Chief Marketing Officer

15. Bio Pharma Market in India 2017 15
Key RatiosFinancial Snapshot
Key Financial Performance Indicators
Indicators Value
Market Capitalization (INR mn)
Total Enterprise Value (INR mn)
EPS (INR)
PE Ratio (Absolute)
Particulars 2013 2014 2015 2016
Profitability Ratios
Gross Margin %
Net Income Margin %
EBITDA Margin %
EBITA Margin %
EBIT Margin %
Return on Assets %
Return on Capital %
Return on Equity %
Return on Common Equity %
Liquidity Ratios
Current Ratio
Quick Ratio
Leverage Ratios
Total Debt/Equity
Total Debt/Capital
Interest Coverage
Efficiency Ratios
Total Asset Turnover
Fixed Asset Turnover
Accounts Receivable Turnover
Inventory Turnover
Net Profit / LossTotal Income
x
z
x
c
d
e
a
b
c
d
e
f0
y
FY 2016FY 2015FY 2014FY 2012
Public: Domestic Company – Company A (Contd.)

16. Bio Pharma Market in India 2017 16
Key Business Segments Key Geographic Segments
0%
20%
40%
60%
80%
100%
FY 2015FY 2014FY 2013 FY 2016
Segment 3Segment 2Segment 1
0%
20%
40%
60%
80%
100%
2016FY 2015FY 2014FY 2013
Country 1 Country 2
Public: Domestic Company – Company A (Contd.)

17. Bio Pharma Market in India 2017 17
Company Information
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation
Business Description
• xx
Private: Domestic Company – Company B
Products and Services
Category Products/Services
xx xx
xx xx
xx xx
xx xx
Key People
Name Designation
Person 1 Chief Executive Officer
Person 2 Chief Operating Officer
Person 3 Head – Operations
Person 4 Chief Marketing Officer

18. Bio Pharma Market in India 2017
Recent Developments
18
Date Category Description Impact
Apr 26, 2017 Mergers & Acquisitions High
Feb 24, 2017 Regulatory High
Feb 17, 2017 Product Launch Medium
Feb 07, 2017 Collaborations & Partnerships High

19. About Netscribes, Inc.
Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment &
business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value
proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives.
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage
arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.
Thank you for your attention
Phone: +91 33 4027 6243/6222; +91 33 4027 6200/6207; +91 22 4098 7600
E-Mail: researchonindia@netscribes.com
Bio Pharma Market – India report is part of Netscribes’ Healthcare Industry Series.
For any queries or customized research requirements, contact us at:
Research on India is a product of Netscribes (India) Pvt. Ltd. It is dedicated to disseminating information and providing quick insights on “hot”
industries in India and other emerging markets.
19